Analysis on the Hospital Infections Due to Extended Spectrum Batalaclose-Producing Bacteria
Liu Jia-rui
Abstract
Liu Jia-rui
Abstract
Objective;To investigate the incidence rate and distributed condition of the hospital infections due to extended spectrum batalaclose(ESBLs)-producing bacteria and the antibiotic resistance characterisation of the bacteria in our hospital.Methods:The ESBLs-producing bacteria assays were perfoumed with double-disk synergy test and compunud piece type confirm test.The bactrea identification and drug sesitivity tests were performed weith france bioMerieux-API identification system and K-B method,respectively.Result:Among 480 strains gram-negative bacilli,135 strains were ESBLs-producig bacteria(28.13%).Escherichia coli and klebasiella pneumoniae accounted for 24.89% and 35.34% of the ESBLs-producing bacteria,respectively,The antibiotic resistance rate of ESBLs producign bacteria was significantly higher than the non-ESBLs-producing bacteria(P0.01).The resistance strains to imipenem were not detected.Conclusion:The ESBLs assay should routinely be done in the clinical laboratory bacteria identification,it s helpful to control the spread and epidemic of ESBLs-producing bacteria.Imipenen is first selected drug for treat ESBLs-producing bacteria infections.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective;To investigate the incidence rate and distributed condition of the hospital infections due to extended spectrum batalaclose(ESBLs)-producing bacteria and the antibiotic resistance characterisation of the bacteria in our hospital.Methods:The ESBLs-producing bacteria assays were perfoumed with double-disk synergy test and compunud piece type confirm test.The bactrea identification and drug sesitivity tests were performed weith france bioMerieux-API identification system and K-B method,respectively.Result:Among 480 strains gram-negative bacilli,135 strains were ESBLs-producig bacteria(28.13%).Escherichia coli and klebasiella pneumoniae accounted for 24.89% and 35.34% of the ESBLs-producing bacteria,respectively,The antibiotic resistance rate of ESBLs producign bacteria was significantly higher than the non-ESBLs-producing bacteria(P0.01).The resistance strains to imipenem were not detected.Conclusion:The ESBLs assay should routinely be done in the clinical laboratory bacteria identification,it s helpful to control the spread and epidemic of ESBLs-producing bacteria.Imipenen is first selected drug for treat ESBLs-producing bacteria infections.
Key concepts: Bacteria, Imipenem, Microbiology, Medicine, Drug resistance, Antibiotics, Klebsiella pneumoniae, Virology